Head-to-head · The Match Score
Ondra Health vs Ro
Both scored on the same six-factor Match Score. Ondra Health wins this matchup with a 79 to 74 edge.
Ondra Health
Grade C
Value-seekers who want a flat monthly price, named physicians and a choice of pharmacy, in any state.
Visit Ondra HealthRo
Grade C
Anyone who wants FDA-approved Wegovy or Zepbound and help getting insurance to pay for it.
Visit RoFactor by factor
The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.
Price, coverage & formulary
| Detail | Ondra Health | Ro |
|---|---|---|
| Semaglutide | $149/mo | $348/mo (starting dose, all-in with the membership, brand-name) |
| Tirzepatide | $219/mo | $448/mo (starting dose, all-in with the membership, brand-name) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injectable only | Yes |
| Match Score | 79 · C | 74 · C |
Ondra Health edges out Ro, 79 to 74 on the default Match Score. Ondra Health charges $149 a month for compounded semaglutide and $219 for tirzepatide on its monthly plan, the same at every dose, with every plan length and its pharmacy choices published.
Ro is still a fair pick if its strengths line up with yours — best for: Anyone who wants FDA-approved Wegovy or Zepbound and help getting insurance to pay for it.
Worth a look either way: CoreAge Rx, a partner (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.
Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.
More head-to-heads
Or browse alternatives to Ondra Health and all comparisons.
Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.